Application of the French prognostic score (FPS) to assess overall survival (OS) in a US-based cohort of patients (pts) treated with azacitidine (Aza). Zeidan, A., Sun, Z., Prebet, T., Greenberg, P., Juckett, M., Smith, M., Paietta, E., Gabrilove, J., Erba, H. P., Gore, S., Tallman, M. S., Eastern Cooperative Oncology Grp AMER SOC CLINICAL ONCOLOGY. 2013

View details for Web of Science ID 000335419602483